Furthermore, seventeen meta-analyses (Dunning et al., 1999; Suspitsin et al., 2003; Zhuo et al., 2009; Hu et al., 2010a; Hu et al., 2010b; Zhang et al., 2010; Francisco et al., 2011; He et al., 2011; Ma et al., 2011; Cheng et al., 2012; Dahabreh et al., 2013; Hou et al., 2013; Sagne et al., 2013; Wu et al., 2013; Gonçalves et al., 2014; Diakite et al., 2020a; Diakite et al., 2020b) have been published and tried to describe the connection between TP53 codons 72, IVS3 16 bp, and IVS6+62A > G polymorphisms and BC risk, but their results tended to be contradictory and heterogeneous. This evidence concerns the gene TP53 and breast cancer.